Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Sortilin and the risk of cardiovascular disease
Publication

Publications

Sortilin and the risk of cardiovascular disease

Title
Sortilin and the risk of cardiovascular disease
Type
Article in International Scientific Journal
Year
2013
Authors
Maria Francisca Coutinho
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Mafalda Bourbon
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maria João Prata
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Sandra Alves
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 32 No. 9
Pages: 793-799
ISSN: 0870-2551
Other information
Authenticus ID: P-008-HHJ
Abstract (EN): Plasma low-density lipoprotein cholesterol (LDL-C) levels are a key determinant of the risk of cardiovascular disease, which is why many studies have attempted to elucidate the pathways that regulate its metabolism. Novel Latest-generation sequencing techniques have identified a strong association between the 1p13 locus and the risk of cardiovascular disease caused by changes in plasma LDL-C levels. As expected for a complex phenotype, the effects of variation in this locus are only moderate. Even so, knowledge of the association is of major importance, since it has unveiled a new metabolic pathway regulating plasma cholesterol levels. Crucial to this discovery was the work of three independent teams seeking to clarify the biological basis of this association, who succeeded in proving that SORT1, encoding sortilin, was the gene in the 1p13 locus involved in LDL metabolism. SORT1 was the first gene identified as determining plasma LDL levels to be mechanistically evaluated and, although the three teams used different, though appropriate, experimental methods, their results were in some ways contradictory. Here we review all the experiments that led to the identification of the new pathway connecting sortilin with plasma LDL levels and risk of myocardial infarction. The regulatory mechanism underlying this association remains unclear, but its discovery has paved the way for considering previously unsuspected therapeutic targets and approaches.
Language: Portuguese
Type (Professor's evaluation): Scientific
Contact: francisca_coutinho@yahoo.com
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The phenomenon of migration and cardiovascular risk factors (2018)
Another Publication in a National Scientific Journal
Campelo, M
Stabbed in the right place: The millimetric line between luck and disaster; [Apunhalado no sítio certo: a linha milimétrica entre a sorte e o desastre] (2023)
Another Publication in a National Scientific Journal
Amaral Marques, C; Mil Homens, F; Resende, CX; Fernandes, J; Gouveia, D; Pinho, P; Macedo, F
Social media use by cardiovascular healthcare professionals: Exploring a challenging and ever evolving frontier (2023)
Another Publication in a National Scientific Journal
Vilela, EM; José Pedro Nunes
Smoking in Portugal: Where do we stand today? (2019)
Another Publication in a National Scientific Journal
Pereira, AM
Sacubitril-valsartan in the real world: From theory to clinical practice (2018)
Another Publication in a National Scientific Journal
Fontes-Carvalho R

See all (627)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 16:06:41 | Privacy Policy | Personal Data Protection Policy | Whistleblowing